Pay in 4 interest-free payments of $7.46 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
Barsh, G
Jathar VS, Hirwe R, Desai S, Satoskar RS
Incretin-based drug development As mentioned above, endogenous GLP-1 has a very short half-life (1-2 minutes) due to its rapid degradation by DPP4, limiting its utility for treatment as a therapeutic
The salivary glands of gila monsters produce a GLP-1 peptide that does not have a DPP-4-recognized site leading to the first therapeutic incretin, exenatide - a twice daily subcutaneous injection [25]
A comprehensive survey on the detection, classification, and challenges of neurological disorders
US$ 26.18
US$ 21.39
US$ 26.11
US$ 28.11
US$ 24.96
US$ 24.81
US$ 28.07
![Eevee (166/236) [Sun & Moon: Cosmic Eclipse] SPA Retumbante de Boton Fangoso](https://cdn.shopify.com/s/files/1/0268/5285/1798/files/59824024-eb2f-480a-9abd-8ffc912ef937.png?v=1755125294)
![Marshadow (103/236) [Sun & Moon: Cosmic Eclipse] SPA Arrasador del clan Ghor](https://cdn.shopify.com/s/files/1/0268/5285/1798/files/90c95c98-feef-4a1a-8ef3-f0cb46e7e785.png?v=1755125328)
